PUBLICATIONS (Articles) 
Sorscher E.J. and Brewlow J.L.. Cystic fibrosis: A disorder of calcium stimulated secretion and transepithelial sodium 
transport? Lancet 1:368-370, 1982. 
Sorscher E.J., Accavitti M.A., Keeton D., Steadman E., Frizzell R.A., and Benos D.J.. Antibodies against purified epithelial 
sodium channel protein from renal papilla. Am. J. Physiol. 255 (Cell Physiol. 24): C835-C843, 1988. 
Sariban-Sohraby S., Sorscher E.J., Brenner B.M., and Benos D.J.. Phosphorylation of a single subunit of the epithelial Na* 
channel protein following vasopressin treatment of A6 cells. J. Biol. Chem. 263 :1 3875-1 3879, 1989. 
Brown D., Sorscher E.J., Ausiello D.A., and Benos D.J.. Immunocytochemical localization of Na* channels in rat kidney [ 
medulla. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25:F366-F369, 1989. 
Tousson A., Alley C.D., Sorscher E.J., Brinkley B.R., and Benos D.J.. Immunochemical localization of amiloride-sensitive 
sodium channels in sodium transporting epithelia. J. Cell Sci. 93:349-362, 1989. 
Elgavish A., Esko D.J., Frizzell R.A., Benos D., and Sorscher E.J.. Chinese hamster ovary cell mutants deficient in an anion | 
exchanger functionally similar to the erythroid band 3. Ann. N.Y. Acad. Sci., 574 :1 09-1 12, 1989. 
Sorscher E.J. and Huang Z.. Diagnosis of genetic diseases using the polymerase chain reaction and primer specified 
restriction map modification. Application to cystic fibrosis and retinitis pigmentosa. Lancet, 337 : 1 1 1 5-1 1 1 8, 1 991 . , 
Sorscher E.J., Kirk K., Weaver M.L., Jilling T., Blalock J.E., and LeBouef R.D.. Antisense oligodeoxynucleotide to the cystic r 
fibrosis gene inhibits anion transport in normal cultured sweat duct cells. Proc. Natl. Acad. Sci. USA, 88:7759-7762, 1991 .n 
Benos D.J. and Sorscher E.J.. Transport proteins: Ion channels. In: The Kidney: Physiology and Pathophysiology . G 
Giebisch and D. Seldin, Eds., Raven Press, New York, 1992. 
Sorscher E.J., Fuller C.M., Bridges R.J., Tousson A., Marchase R.B., Brinkley B.R., Frizzell R.A., and Benos D.J.. 
Identification of a 60 kDa membrane protein from T84 cells using antibodies made against a synthetic DIDS binding peptide. 
Am. J. Physiol. (Cell Physiol.), 262:C1 36-C1 47, 1992. 
Hartman J., Frizzell R.A., Rado T.A., Benos D.J., and Sorscher E.J.. Affinity purification of insoluble recombinant fusion , 
proteins containing glutathione-S-transferase. Biotechnology and Bioengineering, 39:828-832, 1992. 
Hartman J., Huang Z., Rado T.A., Peng S., Jilling T., Muccio D.D., and Sorscher E.J.. Recombinant synthesis, purification 
and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. Jour, of Biol. 
Chem., 267:6455-6458, 1992. 
Arispe N., Rojas E., Hartman J., Sorscher E.J., and Pollard H.. Intrinsic anion channel activity of the recombinant first 
nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein. Proc. Natl. Acad. Sci., 89: 1 539-1 543, 
1992. 
Bradbury N.A., Jilling T., Berta G., Sorscher E.J., Bridges R.J., and Kirk K.. Regulation of plasma membrane recycling by 
CFTR. Science, 256 :530-532, 1992. 
Peng S., Sommerfelt M.A., Berta G., Berry A.K., Kirk K., Hunter E., and Sorscher E.J.. Rapid purification of recombinant 
baculovirus using fluorescence activated cell sorting. Biotechniques, 14:274-277, 1993. 
Peng S., Sommerfelt M., Logan J., Huang Z., Jilling T., Kirk K., Hunter E., and Sorscher E.J.. One step affinity isolation 
of recombinant protein using the baculovirus/insect cell expression system. Protein Expression and Purification, 4/2:95-100, 
1 993 . ■ 
Garver R.I., Goldsmith B.S., Rodu B., Hu P.-C., Sorscher E.J. and Curiel D. Strategy for achieving selective killing of ; 
carcinomas. Nature Gene Therapy. (In press.) 
Sommerfelt M.A. and Sorscher E.J.. Use of Fluorescence-Activated Cell Sorting for Rapid Isolation of Insect Cells Harboring J 
Recombinant Baculovirus. Methods in Cell Biology, (in press). 
Sorscher E.J., Peng S., Bebok Z., Allan P.W., Bennett, Jr. L.L., Parker W.B.. Tumor Cell Bystander Killing in Colonic 
Carcinoma Utilizing the E.coli Deo D Gene to Generate Toxic Purines (Submitted, J.B.C.) 
Kirk K.L., Weaver-Green M., Berta G., Jilling T., Sorscher E.J., and Elton T.S.. Expression of a rab 3 isoform in secretory [ 
epithelial cells. (Submitted J.B.C.). | 
Logan J., Hiestand D., Daram P., Huang Z., Muccio D.D., Haley B., Cook W. and Sorscher E.J.. CFTR mutations which | 
disrupt nucleotide binding. (Submitted J.C.I.). J 1 
Logan J., Bebok Z, Walker L., Feigner P., Burgess S., Shaw W., Siegal G., Frizzell R., Dong J., Matalon S., Duvall M., '? 
Sorscher E.J.. Cationic lipids for CFTR gene transfer (in preparation). j 
Bebok Z., Logan J., Walker L., Burgess S., Shaw W., Frizzell R., Dong J., Sorscher E.J.. Plasmid Delivery is Not a Limiting 1 
factor in lipid mediated gene transfer In Vitro (in preparation). 
Hughes B., Parker W.B., Gadi V.K., Garver R.l, and Sorscher E.J.. Gene transfer based melanoma therapy using the human j 
tyrosinase promotor (in preparation). f 
PHS 398 (Rev. 9/91) (Form Page 6) Page 
Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 3b. 
[854] Recombinant DNA Research, Volume 18 
"I 
